Difference between revisions of "Team:Duesseldorf"
| Line 73: | Line 73: | ||
<video id="Logo" src="https://static.igem.org/mediawiki/2016/b/b7/T--Duesseldorf--Logo-Animation.mov" autoplay="autoplay" width="100%;" height="auto;"></video> | <video id="Logo" src="https://static.igem.org/mediawiki/2016/b/b7/T--Duesseldorf--Logo-Animation.mov" autoplay="autoplay" width="100%;" height="auto;"></video> | ||
| − | + | <h2>Imagine you turn the switch and the cancer is gone…</h2> | |
| − | <h2 id="Medal_Criteria"> | + | <p> |
| + | Cancer is the second most common cause of death killing about 8.2 million people annually, which equals the total population of New York City. <br> | ||
| + | The global increase of cancer cases and the lack of highly specific therapies for various types of cancer states a clear message:<br> | ||
| + | New approaches have to be found, which allow a level of precision in cancer treatment that has been long-awaited. | ||
| + | <p> | ||
| + | Our approach aims at achieving high spatiotemporal control of apoptosis in tumor cells by applying an optogenetic double-killswitch. This system combines clean removal of cancer cells through apoptosis with the accuracy of light-controlled optogenetics. We utilize two optogenetic proteins, to create a desperately needed holy grail of cancer therapy.<br> | ||
| + | This is the goal of OPTOPTOSIS. | ||
| + | </p> | ||
| + | <h2 id="Medal_Criteria">Our Achievements</h2> | ||
<div class="w3-container" style="margin-bottom:50px;margin-top: 20px;"> | <div class="w3-container" style="margin-bottom:50px;margin-top: 20px;"> | ||
<div class="w3-row"> | <div class="w3-row"> | ||
| Line 87: | Line 95: | ||
</a> | </a> | ||
</div> | </div> | ||
| + | |||
| + | |||
<div id="Bronze" class="w3-container requirement" style="padding-top: 10px;"> | <div id="Bronze" class="w3-container requirement" style="padding-top: 10px;"> | ||
Revision as of 15:44, 18 October 2016
 |
|
Heinrich-Heine University Universitätsstraße 1 40225 Düsseldorf igem@hhu.de facebook.com/igemhhu Design by Marvin van Aalst |
Imagine you turn the switch and the cancer is gone…
Cancer is the second most common cause of death killing about 8.2 million people annually, which equals the total population of New York City.
The global increase of cancer cases and the lack of highly specific therapies for various types of cancer states a clear message:
New approaches have to be found, which allow a level of precision in cancer treatment that has been long-awaited.
Our approach aims at achieving high spatiotemporal control of apoptosis in tumor cells by applying an optogenetic double-killswitch. This system combines clean removal of cancer cells through apoptosis with the accuracy of light-controlled optogenetics. We utilize two optogenetic proteins, to create a desperately needed holy grail of cancer therapy.
This is the goal of OPTOPTOSIS.
Our Achievements
Bronze
Bronze text.
Silver
Silver text.
Gold
Gold text.
